سعر يومان البيومين Uman albumin‏ 20% 1 فيال 50 مل 2026

Uman Albumin 20% (200 g/l): human albumin solution for intravenous infusion, 50 ml vial containing 10 g albumin; hyperoncotic plasma-derived colloid (Kedrion).

• Rare mild reactions (flush, urticaria, fever, nausea) usually resolve when the infusion is slowed or stopped; very rarely shock. Post-marketing (frequency not known): hypotension, tremor, dyspnoea, erythema, urticaria, pruritus, chills, pyrexia.International label, same product · Israel Ministry of Health - Israeli Drug Registry

• Hypersensitivity to albumin preparations or to any of the excipients.International label, same product · Israel Ministry of Health - Israeli Drug Registry

• Suspected allergic or anaphylactic reactions require immediate discontinuation of the infusion; treat shock with standard measures.International label, same product · Israel Ministry of Health - Israeli Drug Registry
• Use with caution where hypervolaemia or haemodilution is a special risk: decompensated cardiac insufficiency, hypertension, oesophageal varices, pulmonary oedema, haemorrhagic diathesis, severe anaemia, renal and post-renal anuria.International label, same product · Israel Ministry of Health - Israeli Drug Registry
• The 20% solution has about four times the colloid-osmotic effect of plasma; ensure adequate hydration and guard against circulatory overload. It is relatively low in electrolytes - monitor electrolyte status.International label, same product · Israel Ministry of Health - Israeli Drug Registry

• Other medicinal productsNo specific interactions of human albumin with other medicinal products are known.Israel Ministry of Health - Israeli Drug Registry

• Safety in pregnancy not established in controlled trials, but clinical experience suggests no harmful effects on pregnancy, foetus or neonate; pay particular attention to volume substitution in pregnant patients.International label, same product · Israel Ministry of Health - Israeli Drug Registry
• Human albumin is a normal blood constituent; treatment of a nursing mother is not expected to present a risk to the breast-fed infant.International label, same product · Israel Ministry of Health - Israeli Drug Registry